Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease.
Sci Rep. 2021 Feb 25;11(1):4722. doi: 10.1038/s41598-021-84194-w.
Sci Rep. 2021.
PMID: 33633318
Free PMC article.